Weill Cornell Medicine professor receives major grant for pediatric pain management study

Phar­ma­ceu­ti­cal in­dus­try groups cau­tion that Pres­i­dent Don­ald Trump’s tar­iffs on Chi­na, Mex­i­co and Cana­da will like­ly ex­ac­er­bate ex­ist­ing drug short­ages in the US, raise drug

De­spite months of bio­phar­ma in­dus­try push­back, the Eu­ro­pean Com­mis­sion has un­con­di­tion­al­ly ap­proved No­vo Hold­ings’ $16.5 bil­lion ac­qui­si­tion of Catal­ent. The Fed­er­al Trade … Sign up

AbbVie has completed the acquisition of Nimble Therapeutics. Credit: © AbbVie Inc. All rights reserved. AbbVie and Neomorph are forming a partnership and option-to-license agreement